Related Experiment Videos
Neonatal pancreatic function in infants born to mothers with gestational and overt diabetes
Insights
Infants born to mothers with gestational diabetes (GD) show exaggerated pancreatic function, indicated by higher C-peptide levels. This heightened response in newborns correlates with increased birth weight, suggesting intrinsic pancreatic differences.
Area of Science:
- Endocrinology
- Neonatal Medicine
- Reproductive Health
Background:
- Maternal diabetes, including gestational diabetes (GD) and overt diabetes (OD), can impact fetal development.
- Neonatal pancreatic function is a key indicator of fetal adaptation to the maternal metabolic environment.
- Understanding these effects is crucial for managing infant health outcomes post-delivery.
Purpose of the Study:
- To assess and compare neonatal pancreatic function in infants born to mothers with GD and OD versus non-diabetic mothers.
- To investigate the relationship between neonatal pancreatic function, cord C-peptide/glucose ratios, and birth weight in these infant groups.
Main Methods:
- Utilized cord blood C-peptide estimations to evaluate pancreatic insulin secretion in neonates.
- Calculated cord C-peptide/glucose ratios as a marker of pancreatic response relative to glucose levels.
- Compared these markers across three groups: infants of non-diabetic mothers, mothers with GD, and mothers with OD.
Main Results:
- Infants born to mothers with GD exhibited exaggerated pancreatic function, evidenced by elevated cord C-peptide levels and C-peptide/glucose ratios.
- These increased pancreatic function markers in the GD group correlated significantly with higher birth weight ratios.
- The observed differences could not be solely attributed to maternal hyperglycemia.
Conclusions:
- Neonatal pancreatic function appears intrinsically different in infants exposed to gestational diabetes.
- Exaggerated pancreatic response in infants of mothers with GD may contribute to increased fetal growth.
- Further research is warranted to elucidate the specific mechanisms underlying these observed pancreatic differences.
Abstract:
Neonatal pancreatic function was assessed in infants born to non-diabetic mothers and to mothers with well-controlled gestational diabetes (GD) and overt diabetes (OD) using cord blood C-peptide estimations and the calculation of cord C-peptide/glucose ratios. Exaggerated pancreatic function was present in infants born to mothers with GD. In these infants the increased cord C-peptide values and cord C-peptide/glucose ratios correlated with their increased birth weight ratios. These results could not be explained on the basis of maternal hyperglycaemia and a possible intrinsic difference in pancreatic response between infants born to mothers with GD and those born to mothers with OD is suggested.